HCPLive Network

AAN 2012: Interview with Dr. Zigmond about Exercise and Parkinson’s Disease Study [Podcast]

In this interview, Michael Zigmond, PhD, Professor of Neurology at theUniversity of Pittsburgh, discusses why he became involved with studying Parkinson’s disease and his research on exercise and Parkinson’s disease which he will be presenting at this year's AAN conference.

When asked about how he began his research in Parkinson's disease, Zigmond said, "I became interested in catecholamines, which includes dopamine and norepinephrine primarily, as a graduate student. There was evidence that they were affected by stress and I was interested in looking at the adaptive effects of stress."

It was upon collaborating with colleague when Zigmond explained how he "discovered that... physicial exercise was what we would call 'neuroprotective.' If you had animals exercise before you expose them to a toxin like 6-Hydroxydopamine, the effects of the toxin on the animals' behavior and on the dopamine neurons themselves was reduced."


 


Further Reading
A high-dose influenza vaccine produces a stronger immune response than the standard vaccine in frail seniors under care in nursing homes, according to a new study published online Dec. 17 in the Journal of Infectious Diseases.
Fredy Revilla, MD, never met a mountain he didn’t like. The neurologist has found a connection between his passion for climbing and his profession of caring for patients with neurological disorders.
An article published recently in the journal Diabetes Research and Clinical Practice reviews the mechanisms by which microalbuminuria causes renal and cardiovascular disease. The authors also describe appropriate interventions.
More Reading
A high-dose influenza vaccine produces a stronger immune response than the standard vaccine in frail seniors under care in nursing homes, according to a new study published online Dec. 17 in the Journal of Infectious Diseases.